Cerulean Pharma Inc. is a clinical-stage biopharmaceutical company specializing in the design and development of nanopharmaceuticals. Cerulean’s nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance efficacy and tolerability of therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 12/01/11 | Series D | 15M | CVF, Henry Crown and Company | Unknown |